PerkinElmer Reports 1 Percent Bump in Q2 Revenues | GenomeWeb

This article has been updated to include comments from PerkinElmer's Q2 conference call.

NEW YORK (GenomeWeb) – PerkinElmer reported after the close of the market on Thursday a 1 percent increase in its second quarter revenues, or 8 percent on a constant-currency basis.

For the three months ended June 28, PerkinElmer's revenues rose to $563.9 million from $556.2 million for the same period a year ago,beating analysts' average estimate of $555.5 million. The company reported organic revenue growth of 4 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.